GLP-1 injections are utilized for medical weight loss by enhancing satiety and slowing digestion, effectively helping patients reduce calorie intake and manage their weight
Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes
2021;12:1321 Chen J, Ren H, Zhou P, Zheng S, Du B, Liu X, et al
A detailed medical evaluation helps identify any underlying conditions that could make GLP-1 treatment unsuitable, such as a history of thyroid cancer, pancreatitis, or certain gastrointestinal issues